Pharmacological activation of ATF6 remodels the proteostasis network to rescue pathogenic GABA A receptors.

receptor activity in diseases including genetic epilepsy and point to the potential for similar pharmacologic enhancement of ER proteostasis to improve trafficking of other disease-associated variant ion channels implicated in etiologically-diverse diseases.